Massachusetts medical device maker Medrobotics won CE Mark approval in the European Union for its Flex System, a robot-assisted surgical device indicated for use in otolaryngology surgery.
Medrobotics
Medrobotics rounds up a Herculean $10M for robotic surgery device
Medrobotics said landed a $10 million debt round ahead of the anticipated commercial launch for its Flex robotic system here and across the pond.
The Raynham, Mass.-based medical device company said the loans package is from a Hercules Technology Growth Capital affiliate and "precedes Medrobotics’ anticipated commercial launches in Europe and the United States," according to a press release.
Medrobotics’ flagship Flex is a surgical-assist device designed to navigates internal body cavities using visual and tactile feedback.
Surgical robot maker Medrobotics lands $33.6M in Series D
Surgical robotics company Medrobotics raised $33.6 million in Series D round of funding from new and existing investors, according to a company statement.
The Raynham, Mass.-based medical device maker, originally known as Cardiorobotics, plans to use the proceeds to prepare regulatory submissions and prepare for commercial launch in the U.S. and Europe, which it expects may begin next year.
AngioDynamics’ executive VP & CFO retires | Personnel Moves
AngioDynamics loses EVP & CFO
Albany, N.Y.-based AngioDynamics’ executive vice president & CFO Joseph Gersuk retired from the company, effective January 31, 2013.
Funding: Medrobotics aims for $20 million in new funding round
Surgical robotics company Medrobotics is on its way to a $20 million funding round, having raised $8.1 million so far.
The Raynham, Mass.-based medical device company, originally known as Cardiorobotics, is working on a multi-link robot for minimally invasive surgical procedures, hoping to "replace open surgical procedures for many parts of the anatomy that are otherwise difficult or previously impossible to reach," the company’s website says.
Surgical snake maker lands $11.7M in Series C | Funding Roundup
Surgical snake technology developer Medrobotics Corp. closed a $11.7 million Series C funding round led by current shareholders, angel investors and the Pittsburgh Life Sciences Greenhouse.
Medrobotics, originally known as Cardiorobotics, has raised $28.3 million since it spun out of Carnegie Mellon University in 2005.
The Boston, Mass.-based med-tech maker’s robots allow surgeons to perform 2-handed surgeries in hard-to-reach anatomical areas. The robots can support their own weight and move in any 3D space without structural support.